# Antibiotics, Gastric Bypass, and the Microbiome

> **NCT05367479** · PHASE1 · COMPLETED · sponsor: **Medical College of Wisconsin** · enrollment: 23 (actual)

## Conditions studied

- Obesity, Morbid
- Hypertension
- Bariatric Surgery Candidate

## Interventions

- **DRUG:** Antibiotic

## Key facts

- **NCT ID:** NCT05367479
- **Lead sponsor:** Medical College of Wisconsin
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-18
- **Primary completion:** 2020-01-09
- **Final completion:** 2020-01-09
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2022-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05367479

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05367479, "Antibiotics, Gastric Bypass, and the Microbiome". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05367479. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*